This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Davies, S. M. Articles by Perentesis, J. P. Search for Related Content PubMed PubMed Citation Articles by Davies, S. M. Articles by Perentesis, J. P.

Glutathione S-Transferase Polymorphisms in Children with Myeloid Leukemia: A Children’s Cancer Group Study¹

Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota 55455 [S. M. D., L. L. R., G. A. R., J. A. R., J. P. P.], and the Department of Preventive Medicine, University of Southern California, Los Angeles, and Children’s Cancer Group, Arcadia, California 91066 [J. D. B.]

GSTM1 and GSTT1 are polymorphic genes. Absence of enzyme activity is due to homozygous inherited deletion of the gene, reducing detoxification of carcinogens such as epoxides and alkylating agents and potentially increasing cancer risk. We hypothesized that GST null genotype would increase risk of acute myeloid leukemia and myelodysplasia (AML/MDS) in children. DNA was extracted from bone marrow slides of 292 AML/MDS patients. PCR amplification was used to assign GSTM1 and GSTT1 genotypes for cases and controls. Given that the frequency of the null genotype varies by ethnicity and that the majority of the cases were Caucasian, analyses were restricted to 232 white (non-Hispanic) cases and 153 Caucasian non cancer controls. The frequency of GSTM1 null was significantly increased in AML/MDS cases compared with controls {64 versus 47%; odds ratio (OR), 2.0 [95% confidence interval (CI), 1.3–3.1]; P = 0.001}, whereas the frequency of GSTT1 null genotype in AML/MDS cases was not statistically different from controls. AML comprises biologically distinct subtypes, and a test for homogeneity revealed a statistically significant difference among subtypes (P = 0.04; df, 8) for GSTM1 only. In particular, there was an increased frequency of GSTM1 null genotypes in French-American-British groups M3 [82%; n = 22; OR, 5.1 (95% CI, 1.6–21.3)] and M4 [72%; n = 53; OR, 2.9 (95% CI, 1.4–6.0)]. We conclude that the GSTM1 null genotype is a significant risk factor for childhood AML, particularly French-American-British groups M3 and M4. This may indicate an important role for exogenous carcinogens in the etiology of childhood AML.

This article has been cited by other articles:

				A. DeMichele, P. Gimotty, J. Botbyl, R. Aplenc, T. Colligon, A. S. Foulkes, and T. R. Rebbeck In Response to "Drug Metabolizing Enzyme Polymorphisms Predict Clinical Outcome in a Node-Positive Breast Cancer Cohort" J. Clin. Oncol., December 10, 2007; 25(35): 5675 - 5677. [Full Text] [PDF]

				A. DeMichele, R. Aplenc, J. Botbyl, T. Colligan, L. Wray, M. Klein-Cabral, A. Foulkes, P. Gimotty, J. Glick, B. Weber, et al. Drug-Metabolizing Enzyme Polymorphisms Predict Clinical Outcome in a Node-Positive Breast Cancer Cohort J. Clin. Oncol., August 20, 2005; 23(24): 5552 - 5559. [Abstract] [Full Text] [PDF]

				G. H. Reaman Pediatric Cancer Research From Past Successes Through Collaboration to Future Transdisciplinary Research Journal of Pediatric Oncology Nursing, May 1, 2004; 21(3): 123 - 127. [Abstract] [PDF]

				C. Seedhouse, R. Faulkner, N. Ashraf, E. Das-Gupta, and N. Russell Polymorphisms in Genes Involved in Homologous Recombination Repair Interact to Increase the Risk of Developing Acute Myeloid Leukemia Clin. Cancer Res., April 15, 2004; 10(8): 2675 - 2680. [Abstract] [Full Text] [PDF]

				S. M. Davies, S. Bhatia, J. A. Ross, W. R. Kiffmeyer, P. S. Gaynon, G. A. Radloff, L. L. Robison, and J. P. Perentesis Glutathione S-transferase genotypes, genetic susceptibility, and outcome of therapy in childhood acute lymphoblastic leukemia Blood, June 17, 2002; 100(1): 67 - 71. [Abstract] [Full Text] [PDF]

				S. M. Davies, L. L. Robison, J. D. Buckley, T. Tjoa, W. G. Woods, G. A. Radloff, J. A. Ross, and J. P. Perentesis Glutathione S-Transferase Polymorphisms and Outcome of Chemotherapy in Childhood Acute Myeloid Leukemia J. Clin. Oncol., March 1, 2001; 19(5): 1279 - 1287. [Abstract] [Full Text] [PDF]